The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children.

Costaguta GA, Girard C, Groleau V, Grzywacz K, Dirks MH, Deslandres C.

Open source

DOI
10.1093/jcag/gwad042
Published
2023-11-06
Container
J Can Assoc Gastroenterol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jcag/gwad042,
  title = {The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children.},
  author = {Costaguta GA and  Girard C and  Groleau V and  Grzywacz K and  Dirks MH and  Deslandres C.},
  year = {2024},
  journal = {J Can Assoc Gastroenterol},
  doi = {10.1093/jcag/gwad042},
  url = {https://doi.org/10.1093/jcag/gwad042}
}

RIS

TY  - JOUR
TI  - The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children.
AU  - Costaguta GA
AU  -  Girard C
AU  -  Groleau V
AU  -  Grzywacz K
AU  -  Dirks MH
AU  -  Deslandres C.
PY  - 2024
JO  - J Can Assoc Gastroenterol
DO  - 10.1093/jcag/gwad042
UR  - https://doi.org/10.1093/jcag/gwad042
ER  - 

APA

GA, C., C, G., V, G., K, G., MH, D., & C., D. (2024). The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children.. J Can Assoc Gastroenterol. https://doi.org/10.1093/jcag/gwad042

Source records